glp-1 medication shortage No Longer on FDA's Drug List How FDA Crackdowns Are Affecting

Weight is the primary metric by which anti-obesity drugs are judged and distributed, but weight and BMI are poor measures for visceral fat

Right ventricular (RV) dysfunction is a critical complication of pulmonary hypertension (PH) with limited treatment strategies

Are you wondering how to deal with a gaunt face after achieving your ideal weight

Emerging effects of DPP-4 on bone metabolism include an inverse relationship between DPP-4 activity levels and bone mineral density, along with an increased risk of fractures

This move comes as these diabetes and weight-loss drugs see explosive demand in India, fueled by rising obesity rates and recent price reductions